Detailed View
PTGX - Protagonist Therapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
9,438,997,504
Adj EBIT (TTM)
87,513,000
Enterprise Value
8,656,419,504
Last Price
145.87
Earnings Yield
1.01%
Return on Capital
10.32%
Capital
848,363,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 213,475,000 | 158,766,000 |
| 2026-03-31 | 10-Q | 2026 | 56,368,000 | -3,648,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 7,437,000 | -50,355,000 |
| 2025-09-30 | 10-Q | 2025 | 4,712,000 | -46,421,000 |
| 2025-06-30 | 10-Q | 2025 | 5,546,000 | -42,041,000 |
| 2025-03-31 | 10-Q | 2025 | 28,321,000 | -19,310,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 170,638,000 | 126,780,000 |
| 2024-09-30 | 10-Q | 2024 | 4,675,000 | -41,453,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.